Figure 3.
OS of patients stratified according to their clinical parameters. (A) OS of male and female patients separately. (B) OS of patients >70 and ≤70 years of age. (C) OS of patients with acute or lymphoma subtype vs chronic or smoldering subtype. (D) OS according to ECOG PS status (0,1 vs 2-4). (E) OS according to serum sIL-2R levels (>20 000 U/mL vs ≤20 000 U/mL). (F) OS according to serum-adjusted Ca level (≥11.0 mg/dL vs <11.0 mg/dL). (G) OS according to serum Alb level (≥3.5 g/dL vs <3.5 g/dL).

OS of patients stratified according to their clinical parameters. (A) OS of male and female patients separately. (B) OS of patients >70 and ≤70 years of age. (C) OS of patients with acute or lymphoma subtype vs chronic or smoldering subtype. (D) OS according to ECOG PS status (0,1 vs 2-4). (E) OS according to serum sIL-2R levels (>20 000 U/mL vs ≤20 000 U/mL). (F) OS according to serum-adjusted Ca level (≥11.0 mg/dL vs <11.0 mg/dL). (G) OS according to serum Alb level (≥3.5 g/dL vs <3.5 g/dL).

Close Modal

or Create an Account

Close Modal
Close Modal